Jazz Pharmaceuticals plc logo
Jazz Pharmaceuticals plc JAZZ
$ 122.0 -0.7%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Jazz Pharmaceuticals plc Financial Ratios 2011-2024 | JAZZ

Annual Financial Ratios Jazz Pharmaceuticals plc

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

19.8 -39.2 -24.9 39.2 16.0 17.2 18.8 18.6 24.6 181.6 44.6 11.9 17.5

P/S

2.1 2.4 2.7 4.0 3.9 4.1 5.7 5.0 6.1 9.0 11.1 5.9 8.0

EPS

6.5 -3.6 -5.5 4.3 9.2 7.5 8.1 6.6 5.4 1.0 3.7 5.1 3.0

EV (Enterprise Value)

6.71 B 7.91 B 7.61 B 8.3 B 10.2 B 9.82 B 11.2 B 9.94 B 8.86 B 11.9 B 9.95 B 3.89 B 2.17 B

EBITDA per Share

9.62 -0.56 3.3 7.12 15.7 13.6 11.3 11.4 9.51 5.26 6.8 4.52 2.87

EV/EBITDA

38.5 9.5 10.7 10.9 15.0 12.8 13.9 34.2 22.8 12.9 15.7

PEG

-0.05 1.03 1.69 47423.47 0.65 -2.09 0.78 0.82 0.05 -2.47 -1.67 0.15 0.08

P/B

0.7 0.8 0.7 1.4 2.7 2.8 3.4 3.9 5.1 7.7 7.4 3.1 11.4

P/CF

7.5 6.9 10.5 10.4 14.1 11.5 15.9 18.1 16.4 62.9 35.4 15.1 15.0

ROE %

11.10 -7.26 -8.31 6.52 16.82 16.21 17.98 21.14 20.61 4.26 16.70 25.74 64.84

ROA %

3.64 -2.07 -2.68 3.65 9.45 8.59 9.52 8.27 9.89 1.75 9.66 14.68 49.29

ROCE %

15.48 -2.12 4.29 10.33 10.29 12.63 10.95 13.01 15.82 6.26 16.55 11.14 63.08

Current Ratio

- - - - 4.5 3.6 3.3 2.9 5.6 4.7 4.2 2.9 3.8

DSO

64.6 60.6 56.6 58.1 60.1 50.9 50.5 57.4 57.8 58.0 52.2 47.0 46.1

DIO

- - - - 224.3 159.0 143.1 118.1 69.4 93.3 102.6 123.4 102.4

DPO

- - - - 135.7 121.9 80.8 77.6 77.6 78.0 75.1 74.0 133.9

Operating Cycle

64.6 60.6 56.6 58.1 284.4 210.0 193.6 175.6 127.2 151.3 154.8 170.4 148.5

Cash Conversion Cycle

64.6 60.6 56.6 58.1 148.7 88.0 112.8 98.0 49.6 73.2 79.7 96.4 14.6

All numbers in USD currency

Quarterly Financial Ratios Jazz Pharmaceuticals plc

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

3.5 2.68 -0.23 2.33 1.63 1.09 - -0.31 0.56 0.03 - -0.86 -6.11 2.16 2.39 2.67 2.07 -2.82 1.31 1.8 4.62 1.49 2.69 2.47 1.53 0.77 3.87 1.06 1.76 1.44 1.95 1.49 1.89 1.24 1.35 1.43 1.44 1.16 1.35 0.43 0.73 -1.58 0.96 1.3 0.72 0.74 3.46 0.58 0.48 0.51 0.88 0.77 0.81 0.54

EBITDA per Share

6.8 5.64 1.18 5.19 4.84 2.1 - 2.64 3.75 1.54 - 0.78 1.19 2.96 - 3.79 3.74 -3.31 - 2.54 3.72 2.4 - 3.31 2.67 1.53 - 1.59 2.85 2.33 - 2.39 2.87 2.02 - 2.26 2.58 1.96 - 1.05 1.3 -1.12 - 1.76 1.33 1.18 - 0.97 0.7 0.67 - 0.81 0.83 0.56

ROE %

13.45 11.25 8.86 8.54 3.61 1.73 0.41 -0.93 -1.55 -11.43 -6.93 -3.28 2.11 14.04 6.52 5.25 4.49 9.77 16.82 20.23 22.36 17.29 16.21 18.99 15.92 16.46 17.98 15.64 18.08 20.29 21.14 19.77 20.61 20.60 21.98 23.08 19.34 16.43 4.26 2.57 6.52 6.59 16.70 30.31 27.46 26.62 25.74 27.29 41.18 55.98 64.83 16.85 17.22 11.32

ROA %

4.42 3.59 2.74 2.68 1.18 0.26 -0.16 -0.58 -0.83 -3.58 -1.37 0.67 3.36 7.87 3.65 2.95 2.52 5.50 9.45 11.18 12.20 9.25 8.59 10.06 8.43 8.72 9.52 7.42 8.05 8.38 8.27 8.32 9.08 9.33 9.86 9.82 7.97 6.64 1.75 1.77 4.37 4.95 9.66 17.39 15.71 15.21 14.68 19.25 30.38 42.09 49.29 12.81 13.09 8.61

ROCE %

18.27 16.50 14.98 14.09 10.05 8.26 6.00 6.72 6.54 2.18 3.30 8.67 13.31 20.40 5.59 9.87 8.79 9.94 15.14 21.99 24.56 23.55 15.59 18.77 15.11 15.64 14.29 21.55 25.62 28.52 22.70 31.11 32.27 33.88 27.95 32.19 28.01 22.83 4.79 12.55 16.08 16.61 18.97 23.91 21.08 18.64 11.64 29.12 41.67 55.71 46.77 17.48 17.56 11.72

Current Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

61.5 62.6 67.5 58.1 58.8 65.2 - 29.2 28.0 63.7 - 54.8 55.9 60.9 54.4 60.2 64.3 64.2 55.8 60.4 60.8 55.6 50.5 51.3 48.1 50.1 46.9 49.7 51.9 55.6 53.9 57.1 56.1 60.3 56.1 56.1 57.3 58.4 51.8 55.5 58.4 57.5 48.3 49.0 54.7 46.6 37.5 39.2 55.4 48.9 37.5 42.8 48.6 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

61.5 62.6 67.5 58.1 58.8 65.2 - 29.2 28.0 63.7 - 54.8 55.9 60.9 54.4 60.2 64.3 64.2 55.8 60.4 60.8 55.6 50.5 51.3 48.1 50.1 46.9 49.7 51.9 55.6 53.9 57.1 56.1 60.3 56.1 56.1 57.3 58.4 51.8 55.5 58.4 57.5 48.3 49.0 54.7 46.6 37.5 39.2 55.4 48.9 37.5 42.8 48.6 -

Cash Conversion Cycle

61.5 62.6 67.5 58.1 58.8 65.2 - 29.2 28.0 63.7 - 54.8 55.9 60.9 54.4 60.2 64.3 64.2 55.8 60.4 60.8 55.6 50.5 51.3 48.1 50.1 46.9 49.7 51.9 55.6 53.9 57.1 56.1 60.3 56.1 56.1 57.3 58.4 51.8 55.5 58.4 57.5 48.3 49.0 54.7 46.6 37.5 39.2 55.4 48.9 37.5 42.8 48.6 -

All numbers in USD currency